• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Genet Eng Biotechnol . Porphyrin-derived carbon dots for an enhanced antiviral activity targeting the CTD of SARS-CoV-2 nucleocapsid

tetano

Editor, Senior Moderator
J Genet Eng Biotechnol


. 2023 Oct 6;21(1):93.
doi: 10.1186/s43141-023-00548-z. Porphyrin-derived carbon dots for an enhanced antiviral activity targeting the CTD of SARS-CoV-2 nucleocapsid

Azzania Fibriani[SUP] 1 2 [/SUP], Audrey Angelina Putri Taharuddin[SUP] 3 [/SUP], Nicholas Yamahoki[SUP] 3 [/SUP], Rebecca Stephanie[SUP] 3 [/SUP], Jessica Laurelia[SUP] 3 [/SUP], Dian Fitria Agustiyanti[SUP] 4 [/SUP], Popi Hadi Wisnuwardhani[SUP] 4 [/SUP], Marissa Angelina[SUP] 5 [/SUP], Yana Rubiyana[SUP] 4 [/SUP], Ratih Asmana Ningrum[SUP] 4 [/SUP], Andri Wardiana[SUP] 4 [/SUP], Desriani Desriani[SUP] 4 [/SUP], Ferry Iskandar[SUP] 6 7 8 [/SUP], Fitri Aulia Permatasari[SUP] 7 8 9 [/SUP], Ernawati Arifin Giri-Rachman[SUP] 3 6 [/SUP]



Affiliations
Abstract

Background: Since effective antiviral drugs for COVID-19 are still limited in number, the exploration of compounds that have antiviral activity against SARS-CoV-2 is in high demand. Porphyrin is potentially developed as a COVID-19 antiviral drug. However, its low solubility in water restricts its clinical application. Reconstruction of porphyrin into carbon dots is expected to possess better solubility and bioavailability as well as lower biotoxicity.
Methods and results: In this study, we investigated the antiviral activity of porphyrin and porphyrin-derived carbon dots against SARS-CoV-2. Through the in silico analysis and assessment using a novel drug screening platform, namely dimer-based screening system, we demonstrated the capability of the antivirus candidates in inhibiting the dimerization of the C-terminal domain of SARS-CoV-2 Nucleocapsid. It was shown that porphyrin-derived carbon dots possessed lower cytotoxicity on Vero E6 cells than porphyrin. Furthermore, we also assessed their antiviral activity on the SARS-CoV-2-infected Vero E6 cells. The transformation of porphyrin into carbon dots substantially augmented its performance in disrupting SARS-CoV-2 propagation in vitro.
Conclusions: Therefore, this study comprehensively demonstrated the potential of porphyrin-derived carbon dots to be developed further as a promisingly safe and effective COVID-19 antiviral drug.

Keywords: Antivirus; COVID-19; Carbon dots; Coronavirus; Cytotoxicity; Dimer-based screening system; Nucleocapsid; Phytochemicals; Porphyrin; SARS-CoV-2.

 
Back
Top Bottom